Drug Delivery Platforms: Novel BBB-penetrating Systems, Ocular Eye-drop Systems, and Tumor Tissue-targeted Intracellular Approaches
Vanderbilt University
Vanderbilt University is seeking drug delivery platforms for improved CNS, ocular, and tumor tissue targeting.
Reference No.
RFP-2025-3128
Category
Research/Development
Due Date
March 16th, 2026
Description
Daiichi Sankyo is seeking novel drug delivery platform opportunities in three strategic areas: CNS drug delivery, ocular delivery systems, and tumor tissue-targeted delivery technologies.
Key Requirements
RFP Submission Requirements for Vanderbilt Drug Delivery
Contact Information
What you’ll get when you unlock
All the details after a short form. No spam
- Latest RFP PDF
- Buyer contact sheet
- Submission checklist
- Any addenda links